STOCK TITAN

Highbridge Files Schedule 13G/A Disclosing 1,038,240 FLGC Shares (4.4%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Highbridge Capital Management, LLC filed an amendment to Schedule 13G reporting beneficial ownership of 1,038,240 common shares of Flora Growth Corp. (FLGC), representing 4.4% of the outstanding common shares on a fully‑diluted basis assuming exercise of warrants. The shares reported are issuable upon exercise of warrants directly held by funds managed by Highbridge. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The reporting person is a Delaware investment adviser with a New York business address.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: A passive, sub‑5% position via warrants signals modest strategic exposure without control intent.

Highbridge reports a 4.4% interest based on 22,568,653 common shares outstanding as of May 9, 2025, and discloses 1,038,240 warrants exercisable into common shares. Because the position is under 5% and acquired through warrants held by managed funds, this is a routine Section 13G disclosure for an investment adviser rather than an active takeover or control move. The certification clarifies holdings are in the ordinary course of business, which supports a passive investment classification.

TL;DR: Filing is a standard passive disclosure; no governance change or group formation is indicated.

The amendment identifies Highbridge as the reporting person and explicitly states no group affiliation or parent/control company role. No shared voting or dispositive power is reported. The document includes the required certification attesting holdings are not intended to influence control, reinforcing that this is a compliance filing rather than an activist or control‑seeking disclosure.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The 1,038,240 Common Shares (as defined in Item 2(a)) reported herein are issuable upon exercise of warrants.


SCHEDULE 13G



Highbridge Capital Management, LLC
Signature:/s/ Kirk Rule
Name/Title:Kirk Rule, Executive Director
Date:08/14/2025

FAQ

What stake in Flora Growth Corp. (FLGC) does Highbridge report?

Highbridge reports beneficial ownership of 1,038,240 common shares, representing 4.4% of the class on a fully‑diluted basis assuming exercise of warrants.

Are the reported FLGC shares currently outstanding or issuable upon exercise?

The 1,038,240 shares reported are issuable upon exercise of warrants directly held by the Highbridge Funds, per the filing.

Is Highbridge claiming voting or dispositive control over the FLGC shares?

The filing shows sole voting power and sole dispositive power for 1,038,240 shares and zero shared voting or dispositive power.

Does this Schedule 13G/A indicate an attempt to influence control of FLGC?

No. The filing includes a certification stating the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

On what share count is the 4.4% percentage based?

The percentage is calculated using 22,568,653 common shares outstanding as of May 9, 2025, as reported by the issuer.
Flora Growth Corp

NASDAQ:FLGC

FLGC Rankings

FLGC Latest News

FLGC Latest SEC Filings

FLGC Stock Data

21.59M
610.38k
12.54%
4.08%
1.14%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
FORT LAUDERDALE